SPRIM Tackles Peanut Allergy via Prota Therapeutics
18 Jan 2024
US$ 19.00
Singapore-based SPRIM Global Investments (SGI) has led the US$21 million equity and debt financing of Prota...
Tag
Biotech
Related Publications
Primavera Venture Partners has led the pre-series A financing round of OPTIX, joined by Lanchi Ventures, an existing ......
KKR & Co Inc (KKR) has agreed to acquire the corporate trust and wealth management businesses of the ASX-listed asset...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.